{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:04:01Z","timestamp":1783465441234,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/51756-5"],"award-info":[{"award-number":["2012\/51756-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/16082-7"],"award-info":[{"award-number":["2017\/16082-7"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.diagmicrobio.2022.115856","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T02:09:14Z","timestamp":1667786954000},"page":"115856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory"],"prefix":"10.1016","volume":"105","author":[{"given":"Juliana Maira Watanabe","family":"Pinhata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Pires","family":"Brandao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Failde","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros\u00e2ngela Siqueira de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilaine","family":"Ferrazoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0001","unstructured":"WHO consolidated guidelines on drug-resistant tuberculosis treatment. 2019. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK539517\/"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0002","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1183\/13993003.00432-2015","article-title":"Classification of antituberculosis drugs: a new proposal based on the most recent evidence","volume":"46","author":"Caminero","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0003","unstructured":"WHO announces updated definitions of extensively drug-resistant tuberculosis. 2021. Available from: https:\/\/www.who.int\/news\/item\/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0004","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijid.2016.10.021","article-title":"Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings","volume":"56","author":"Sotgiu","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0005","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1128\/JCM.00081-09","article-title":"Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"47","author":"Hillemann","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0006","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/JCM.00201-10","article-title":"Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis","volume":"48","author":"Kiet","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0007","series-title":"Tuberculosis","author":"Migliori","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0008","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1590\/S1806-37132009001200008","article-title":"Cord factor detection and macroscopic evaluation of mycobacterial colonies: an efficient combined screening test for the presumptive identification of Mycobacterium tuberculosis complex on solid media","volume":"35","author":"Sime\u00e3o","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0009","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1099\/jmm.0.000734","article-title":"Growth characteristics of liquid cultures increase the reliability of presumptive identification of Mycobacterium tuberculosis complex","volume":"67","author":"Pinhata","year":"2018","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0010","first-page":"986","article-title":"Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis","volume":"11","author":"Giampaglia","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0011","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diagmicrobio.2016.10.023","article-title":"Modified protocol for drug susceptibility testing of MGIT cultures of Mycobacterium tuberculosis by the MGIT 960","volume":"87","author":"Adami","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0012","doi-asserted-by":"crossref","first-page":"168e71","DOI":"10.1016\/j.mimet.2017.06.007","article-title":"Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs","volume":"139","author":"Gallo","year":"2017","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0013","series-title":"GenoType MTBDRsl ver 1.0. Instructions for use IFU-317-03","author":"Lifescience","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0014","series-title":"Ph.D. thesis. Instituto de Higiene e Medicina Tropical","author":"Machado","year":"2014"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0015","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/AAC.00050-09","article-title":"Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment","volume":"53","author":"Feuerriegel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0016","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.42.5.1295","article-title":"Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis","volume":"42","author":"Alangaden","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0017","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.01357-08","article-title":"Mutations at embB306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis","volume":"53","author":"Starks","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0018","first-page":"95","article-title":"BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT","volume":"41","author":"Hall","year":"1999","journal-title":"Nucl Acids Symp Ser"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2105-15-107","article-title":"MUBII-TB-DB: a database of mutations associated with antibiotic resistance in Mycobacterium tuberculosis","volume":"15","author":"Flandrois","year":"2014","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2022.115856_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150321","article-title":"GenoType MTBDRplus assay for rapid detection of multidrug resistance in Mycobacterium tuberculosis: a meta-analysis","volume":"11","author":"Bai","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0022","unstructured":"SARS-CoV-2 Coronavirus - Genomic Reports. Nuno_Faria. First cases of coronavirus disease (COVID-19) in Brazil, South America (2 genomes, 3rd March 2020).: https:\/\/virological.org\/t\/first-cases-of-coronavirus-disease-covid-19-in-brazil-south-america-2-genomes-3rd-march-2020\/409"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0023","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cmi.2017.11.015","article-title":"Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in S\u00e3o Paulo, Brazil: a cross-sectional study","volume":"24","author":"Gallo","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0024","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1128\/JCM.00429-13","article-title":"Predictive value of molecular drug resistance testing of Mycobacterium tuberculosis isolates in Valle del Cauca, Colombia","volume":"51","author":"Ferro","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0025","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jac\/dkv360","article-title":"Specific gyrA gene mutations predict poor treatment outcome in MDR-TB","volume":"71","author":"Rigouts","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0026","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1128\/JCM.00152-17","article-title":"Increased tuberculosis patient mortality associated with Mycobacterium tuberculosis mutations conferring resistance to second-line antituberculous drugs","volume":"55","author":"Georghiou","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0027","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jac\/dks033","article-title":"gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis","volume":"67","author":"Sirgel","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijid.2021.09.028","article-title":"Characterizing the gene mutations associated with resistance to gatifloxacin in Mycobacterium tuberculosis through whole-genome sequencing","volume":"112","author":"Bi","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0029","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jinf.2010.05.001","article-title":"Mutation characterization of gyrA and gyrB genes in levofloxacin-resistant Mycobacterium tuberculosis clinical isolates from Guangdong Province in China","volume":"61","author":"Yin","year":"2010","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0030","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/JCM.01257-15","article-title":"Diagnostic performance of the new version (v2.0) of GenoType MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study","volume":"53","author":"Tagliani","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0031","doi-asserted-by":"crossref","first-page":"e02169","DOI":"10.1128\/AAC.02169-16","article-title":"Some synonymous and nonsynonymous gyrA mutations in Mycobacterium tuberculosis lead to systematic false-positive fluoroquinolone resistance results with the Hain GenoType MTBDRsl assays","volume":"61","author":"Ajileye","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0032","series-title":"WHO Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance","year":"2021"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0033","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760200055","article-title":"Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from S\u00e3o Paulo, Brazil","volume":"115","author":"Matsui","year":"2020","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0034","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1128\/JCM.01947-09","article-title":"Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates","volume":"48","author":"Brossier","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0035","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.5588\/ijtld.18.0562","article-title":"Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs","volume":"23","author":"Chandak","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120470","article-title":"Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review","volume":"10","author":"Avalos","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0037","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bjid.2016.01.004","article-title":"Evaluation of resistance acquisition during tuberculosis treatment using whole genome sequencing","volume":"20","author":"Silva Feliciano","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0038","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/AAC.00050-09","article-title":"Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment","volume":"53","author":"Feuerriegel","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0039","doi-asserted-by":"crossref","first-page":"e33275","DOI":"10.1371\/journal.pone.0033275","article-title":"Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review","volume":"7","author":"Georghiou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2016.06.011","article-title":"Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China","volume":"89","author":"Zeng","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0041","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1038\/s41598-021-87516-0","article-title":"Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait","volume":"11","author":"Al-Mutairi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0042","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1128\/AAC.49.9.3794-3802.2005","article-title":"Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance","volume":"49","author":"Hazb\u00f3n","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2022.115856_bib0043","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1128\/AAC.49.6.2218-2225.2005","article-title":"Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol","volume":"49","author":"Parsons","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322002206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889322002206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:57:54Z","timestamp":1760003874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889322002206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0732889322002206"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115856","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GenoType MTBDRsl for detection of second-line drugs and ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis isolates at a high-throughput laboratory","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2022.115856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115856"}}